"Antibodies, Monoclonal" - Books

Result Filters

Results: 1 to 20 of 913 books (10447 items)

<< First< Prev

Page of 46

Next >Last >>

Select item 15027921.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet].

Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.

Top results in this book Table of Contents

Select item 26591822.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Top results in this book Table of Contents

Select item 44036683.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Top results in this book Table of Contents

Select item 48538164.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

Top results in this book Table of Contents

Select item 45657285.

Drugs and Lactation Database (LactMed®) [Internet].

Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Top results in this book Table of Contents

Select item 14152806.

Madame Curie Bioscience Database [Internet].

Austin (TX): Landes Bioscience; 2000-2013.

Top results in this book Table of Contents

Select item 16686907.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

Top results in this book Table of Contents

Select item 44923128.

Ustekinumab (Stelara) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.

Top results in this book Table of Contents

Select item 46090289.

Certolizumab Pegol (Cimzia) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep.

Top results in this book Table of Contents

Select item 449144010.

Reslizumab (Cinqair) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.

Top results in this book Table of Contents

Select item 331820011.

Golimumab (Simponi) (Subcutaneous Injection): Adult Patients with Moderately to Severely Active Ulcerative Colitis Who Have Had an Inadequate Response to, or Have Medical Contraindications for, Conventional Therapies [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Nov.

Top results in this book Table of Contents

Select item 438087612.

Entyvio (Vedolizumab) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Dec.

Top results in this book Table of Contents

Select item 436751813.

Ustekinumab (Stelara) Injection [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.

Top results in this book Table of Contents

Select item 330659014.

Tocilizumab (Actemra, Intravenous): For the Treatment of Signs and Symptoms of Active Polyarticular Juvenile Idiopathic Arthritis in Patients Two Years of Age and Older Who Have Responded Inadequately to Previous Therapy With Disease-Modifying Antirheumatic Drugs and Systemic Corticosteroids [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Aug.

Top results in this book Table of Contents

Select item 426217615.

Omalizumab (Xolair): Treatment of Adults and Adolescents (12 Years of Age and above) with Chronic Idiopathic Urticaria [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.

Top results in this book Table of Contents

Select item 422088016.

Ranibizumab (Lucentis): Visual Impairment due to Choroidal Neovascularization Secondary to Pathologic Myopia [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.

Top results in this book Table of Contents

Select item 340129417.

Endotext [Internet].

Feingold KR, Anawalt B, Blackman MR, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

Top results in this book Table of Contents

Select item 436667418.

Denosumab (Xgeva) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.

Top results in this book Table of Contents

Select item 477632619.

Clinical Review Report: Benralizumab (Fasenra): (AstraZeneca Canada Inc.): Indication: An add-on maintenance treatment of adult patients with severe eosinophilic asthma [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.

Top results in this book Table of Contents

Select item 466909420.

Clinical Review Report: sarilumab (Kevzara) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 May.

Top results in this book Table of Contents

<< First< Prev

Page of 46

Next >Last >>

Supplemental Content

Images search in Bookshelf

FIGURE 45.5

Examples of different glycan antigens recognized by specific monoclonal antibodies. The antigens have the structures shown within the boxed area and are named as indicated. Usually, the antigen shown in the box can be linked to almost any glycan and antibodies will still recognize the antigen.
Symbol Key:

Antibodies and Lectins in Glycan Analysis.

Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology. 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2009.
FIGURE 45.6

Additional examples of different glycan antigens recognized by specific monoclonal antibodies. The antigens have the structures shown within the boxed area and are named as indicated. Usually, the antigen shown in the box can be linked to almost any glycan and antibodies will still recognize the antigen. Antibodies are also available to glycosaminoglycans and to many glycolipid antigens, including globoside, GD3, GD2, GM2, GM1, asialo-GM1, GD1a, GD1b, GD3, and GQ1b.
Symbol Key:

Antibodies and Lectins in Glycan Analysis.

Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology. 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2009.
Figure 6

(A) p380 is not p300. AT-2 cardiomyocytes were radiolabeled and processed as described in the legend to (Figure 3) was then reacted with an anti-p300 monoclonal antibody (lane 1), with a non-specific antibody (lane 2), with an anti-p53 monoclonal antibody PAb-421 (lane 3) or with an anti-T-Ag monoclonal antibody PAb-419 (lane 4). The anti-p300 antibody fails to immune precipitate p380. (B) p380 binds directly to p53. Mouse ES cells were radiolabeled and processed as described above, and the resulting lysate was reacted with anti-p53 monoclonal antibody PAb-246 (lane 1), with anti-p53 monoclonal antibody PAb-421 (lane 2), or with a non-specific antibody (lane 3). p380 was present in immune complex generated with two anti-p53 antibodies, but not in control immune complex. Since the ES cells do not express T-Ag, these data indicate that p380 binds to p53 directly.

Regulation of Cardiomyocyte Proliferation and Apoptosis.

Madame Curie Bioscience Database [Internet]. Austin (TX): Landes Bioscience; 2000-2013.
Figure 59-1

Recurrent melanoma, unresponsive to radiotherapy, prior to immunotherapy with intralesional injections of human monoclonal antibody to GM₂ or GD₂. (Four-color version of figure on CD-ROM)

Therapy with Unmodified Monoclonal Antibodies.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker; 2003.